Advances in dual-targeting inhibitors of HDAC6 for cancer treatment.
Gu Z, Lin S, Yu J, Jin F, Zhang Q, Xia K, Chen L, Li Y, He B.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2024.116571 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för edelinontrine. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
8 träffarOpportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases.
Li Q, Liao Q, Qi S, Huang H, He S, Lyu W, Liang J, Qin H, Cheng Z, Yu F, Dong X, Wang Z, Han L, Han Y.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2024.116386An overview of phosphodiesterase 9 inhibitors: Insights from skeletal structure, pharmacophores, and therapeutic potential.
Zheng L, Zhou ZZ.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2023.115682BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor.
Meibom D, Micus S, Andreevski AL, Anlauf S, Bogner P, von Buehler CJ, Dieskau AP, Dreher J, Eitner F, Fliegner D, Follmann M, Gericke KM, Maassen S, Meyer J, Schlemmer KH, Steuber H, Tersteegen A, Wunder F.
J Med Chem · research-article; journal article · DOI 10.1021/acs.jmedchem.2c01267Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.
Xi M, Sun T, Chai S, Xie M, Chen S, Deng L, Du K, Shen R, Sun H.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2022.114170Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010-2020).
Li Y, Sang S, Ren W, Pei Y, Bian Y, Chen Y, Sun H.
Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2021.113874Elucidation of fluorine's impact on p<i>K</i><sub>a</sub> and <i>in vitro</i> Pgp-mediated efflux for a series of PDE9 inhibitors.
Fjelbye K, Marigo M, Clausen RP, Jørgensen EB, Christoffersen CT, Juhl K.
Medchemcomm · research-article; journal article · DOI 10.1039/c8md00114fDesign and discovery of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a selective brain penetrant PDE9A inhibitor for the treatment of cognitive disorders.
Verhoest PR, Fonseca KR, Hou X, Proulx-Lafrance C, Corman M, Helal CJ, Claffey MM, Tuttle JB, Coffman KJ, Liu S, Nelson F, Kleiman RJ, Menniti FS, Schmidt CJ, Vanase-Frawley M, Liras S.
J Med Chem · journal article · DOI 10.1021/jm3007799